Submitting your materials

Important notice

International Psychogeriatrics will cease publishing with Cambridge University Press on 31 December 2024. It will continue to be published by Elsevier as of 1 January 2025.

For journal information, please visit Home Page: International Psychogeriatrics.

The Cambridge submission site will close to new submissions on Tuesday, 29 October. Authors wishing to submit their research to the journal should do so at the journal's new submission site.

Submission of manuscripts

It is not acceptable to submit an article to the journal that has been previously published or is being submitted simultaneously elsewhere. Authors are required to assert that they have not submitted their article elsewhere upon submission to International Psychogeriatrics.

Manuscripts should be submitted online via our manuscript submission and tracking site, https://www.editorialmanager.c.... Full instructions for electronic submission are available directly from this site.

To facilitate rapid reviewing, communications for peer review will be electronic and authors will need to supply a current e-mail address when registering to use the system.

When submitting your manuscript you will need to supply each of the following:

A cover letter
The manuscript as a text file in MS Word format (font Arial, minimum size 11)
Up to 5 suggested reviewers, including their names, institutions, email addresses, and the reason for their appropriateness as reviewers for your article
All figures in TIFF or JPEG format.

If the paper reports the results of a randomized controlled trial please ensure that it conforms to our requirements listed below under the heading ‘Submission of randomized clinical trials’ section of these instructions. If the research was paid for by a funding organization, the cover letter must contain the following three statements (this information does not have to be included in the manuscript itself but only in the cover letter). If the research was not paid for by a funding organization only the third statement is required:

That the authors have not entered into an agreement with the funding organization that has limited their ability to complete the research as planned and publish the results.
That the authors have had full control of all the primary data.
That the authors are willing to allow the journal to review their data if requested.

Submission of a manuscript will be taken to imply that all listed authors have seen the final version and approved it.

All papers judged to be appropriate for further review will be assessed by two or more reviewers. The Editor-in-Chief’s decision to accept, reject or request revision of the paper for publication will be final. The abstract and author details will be seen by prospective reviewers of the manuscript. Authors should suggest the names and contact information of experts qualified to review the work, but the Editor-in-Chief is not obliged to follow these suggestions. Papers must bear the authors’ names, titles (e.g., Dr, Professor, etc.), affiliation(s), and address(es). This information will be seen by reviewers. Reviewers’ names will not be supplied to authors unless a reviewer asks to be so identified. Authors will be provided with a copyright transfer form to sign after acceptance of the manuscript, consenting to publication of the paper in International Psychogeriatrics.

All submissions are acknowledged electronically upon receipt. Most authors can expect to receive an initial decision regarding their paper together with referees’ reports within 8 to 10 weeks of submission. Authors who have received no further communication 90 days after acknowledgment of receipt of their article should contact ipaj-ed@cambridge.org.

General notes

Following acceptance of a manuscript the contact author should receive proofs within 1-12 weeks. They also will be required to complete and forward a copyright form and authors’ checklist both of which will be forwarded to the corresponding author by email when the article is accepted.

The average time from an article being accepted to being e-published ahead of print as a First View article is 35 days, provided authors return proofs promptly. E-publication generates a doi number and counts as full publication for citation purposes.

Editorials and commentaries are commissioned by the editor.

Reviewers who reviewed papers in the previous calendar year will be acknowledged in the journal each year. International Psychogeriatrics no longer publishes an annual index as modern computerised search techniques have rendered annual hard copy indices obsolete.

Contributors should refer to recent issues of the journal for examples of formatting (abstracts, headings, references, tables, etc.).

ORCID

We require all corresponding authors to identify themselves using ORCID when submitting a manuscript to this journal. ORCID provides a unique identifier for researchers and, through integration with key research workflows such as manuscript submission and grant applications, provides the following benefits:

Discoverability: ORCID increases the discoverability of your publications, by enabling smarter publisher systems and by helping readers to reliably find work that you have authored.
Convenience: As more organisations use ORCID, providing your iD or using it to register for services will automatically link activities to your ORCID record, and will enable you to share this information with other systems and platforms you use, saving you re-keying information multiple times.
Keeping track: Your ORCID record is a neat place to store and (if you choose) share validated information about your research activities and affiliations.

See our ORCID FAQs for more information.

If you don’t already have an iD, you will need to create one if you decide to submit a manuscript to this journal. You can register for one directly from your user account on ScholarOne, or alternatively via https://ORCID.org/register.

If you already have an iD, please use this when submitting your manuscript, either by linking it to your ScholarOne account, or by supplying it during submission using the "Associate your existing ORCID iD" button.

ORCIDs can also be used if authors wish to communicate to readers up-to-date information about how they wish to be addressed or referred to (for example, they wish to include pronouns, additional titles, honorifics, name variations, etc.) alongside their published articles. We encourage authors to make use of the ORCID profile’s “Published Name” field for this purpose. This is entirely optional for authors who wish to communicate such information in connection with their article. Please note that this method is not currently recommended for author name changes: see Cambridge’s author name change policy if you want to change your name on an already published article. See our ORCID FAQs for more information.

Copyright transfer

Before Cambridge can publish your manuscript, we need a signed copyright transfer agreement. For full details see the publishing agreement page.